TMCI
TREACE MEDICAL CONCEPTS INC
$25.72
Earnings Summary
Revenue | $29.97Mn |
Net Profits | $-17.23Mn |
Net Profit Margins | -57.51% |
Highlights
TREACE MEDICAL CONCEPTS INC’s revenue jumped 45.09% since last year same period to $29.97Mn in the Q2 2022. On a quarterly growth basis, TREACE MEDICAL CONCEPTS INC has generated 3.17% jump in its revenue since last 3-months.
TREACE MEDICAL CONCEPTS INC’s net profit fell -239.05% since last year same period to $-17.23Mn in the Q2 2022. On a quarterly growth basis, TREACE MEDICAL CONCEPTS INC has generated -90.73% fall in its net profits since last 3-months.
TREACE MEDICAL CONCEPTS INC’s net profit margin fell -133.68% since last year same period to -57.51% in the Q2 2022. On a quarterly growth basis, TREACE MEDICAL CONCEPTS INC has generated -84.87% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the TREACE MEDICAL CONCEPTS INC post its latest quarter earnings
EPS Estimate Current Quarter | -0.14 |
EPS Estimate Current Year | -0.14 |
Highlights
TREACE MEDICAL CONCEPTS INC’s earning per share (EPS) estimates for the current quarter stand at -0.14 - a 51.72% jump from last quarter’s estimates.
TREACE MEDICAL CONCEPTS INC’s earning per share (EPS) estimates for the current year stand at -0.14.
Key Ratios
Key ratios of the TREACE MEDICAL CONCEPTS INC post its Q4 2022 earnings
Return on Assets (ROA) | -0.15 |
Return on Equity (ROE) | -0.56 |
Highlights
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. TREACE MEDICAL CONCEPTS INC’s return on assets (ROA) stands at -0.15.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. TREACE MEDICAL CONCEPTS INC’s return on equity (ROE) stands at -0.56.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-03-04 | -0.01 | -0.12 | -1968.97% |
2021-05-25 | -0.06 | -0.07 | -16.67% |
2021-08-05 | -0.12 | -0.1 | 16.67% |
2021-11-04 | -0.12 | -0.12 | 0% |
Company Information
Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.
Organisation | TREACE MEDICAL CONCEPTS INC |
Headquarters | 203 Fort Wade Road, Ponte Vedra, FL, United States, 32081 |
Employees | 423 |
Industry | Healthcare |
CEO | John T. Treace |
